Two new biomarkers, mesothelin and HE4, for diagnosis of ovarian carcinoma
Author:
Publisher
Informa Healthcare
Subject
Biochemistry, medical,Molecular Medicine,Biomedical Engineering,General Medicine
Link
http://www.tandfonline.com/doi/pdf/10.1517/17530059.2011.559459
Reference102 articles.
1. Cancer Statistics, 2009
2. Ovarian Carcinoma Subtypes Are Different Diseases: Implications for Biomarker Studies
3. The Preclinical Natural History of Serous Ovarian Cancer: Defining the Target for Early Detection
4. Differences in Tumor Type in Low-stage Versus High-stage Ovarian Carcinomas
5. Intercepting pelvic cancer in the distal fallopian tube: Theories and realities
Cited by 37 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Deciphering the potential of proteomic-based biomarkers in women’s reproductive diseases: empowering precision medicine in gynecology;Biomarkers;2024-01-02
2. A predictive and prognostic model for surgical outcome and prognosis in ovarian cancer computed by clinico-pathological and serological parameters (CA125, HE4, mesothelin);Clinical Chemistry and Laboratory Medicine (CCLM);2023-10-11
3. Evaluation of He4 Use in the Diagnosis of Ovarian Cancer: First and Second Recurrence, and an Analysis of HE4 Concentration during Second- and Third-Line Chemotherapy;Diagnostics;2023-01-26
4. Exosomes: A potential tool for immunotherapy of ovarian cancer;Frontiers in Immunology;2023-01-18
5. The Role of Mesothelin Expression in Serous Ovarian Carcinoma: Impacts on Diagnosis, Prognosis, and Therapeutic Targets;Cancers;2022-05-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3